MEI Pharma, Inc.

MEI Pharma, Inc.verified

MEIP

Price:

$3.07

Market Cap:

$20.45M

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical tr...[Read more]

Industry

Biotechnology

IPO Date

2003-12-18

Stock Exchange

NASDAQ

Ticker

MEIP

The Enterprise Value as of November 2025 (TTM) for MEI Pharma, Inc. (MEIP) is 10.34M

According to MEI Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.34M. This represents a change of -10.94% compared to the average of 11.61M of the last 4 quarters.

MEI Pharma, Inc. (MEIP) Historical Enterprise Value (quarterly & annually)

How has MEIP Enterprise Value performed in the past?

The mean historical Enterprise Value of MEI Pharma, Inc. over the last ten years is 124.24M. The current 10.34M Enterprise Value has changed 732.16% with respect to the historical average. Over the past ten years (40 quarters), MEIP's Enterprise Value was at its highest in in the June 2020 quarter at 427.10M. The Enterprise Value was at its lowest in in the December 2024 quarter at -7348020.00.

Quarterly (TTM)
Annual

Average

124.24M

Median

74.80M

Minimum

-1553390.00

Maximum

363.50M

MEI Pharma, Inc. (MEIP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MEI Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 123.75%

Maximum Annual Enterprise Value = 363.50M

Minimum Annual Increase = -110.16%

Minimum Annual Enterprise Value = -1553390.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-1553390.00-110.16%
202415.28M-61.45%
202339.64M-43.19%
202269.79M-78.24%
2021320.67M-11.78%
2020363.50M114.23%
2019169.68M13.17%
2018149.93M87.82%
201779.82M123.75%
201635.67M21.04%

MEI Pharma, Inc. (MEIP) Average Enterprise Value

How has MEIP Enterprise Value performed in the past?

The current Enterprise Value of MEI Pharma, Inc. (MEIP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

17.79M

5-year avg

88.77M

10-year avg

124.24M

MEI Pharma, Inc. (MEIP) Enterprise Value vs. Peers

How is MEIP’s Enterprise Value compared to its peers?

MEI Pharma, Inc.’s Enterprise Value is greater than MetaVia Inc. (-1392365.00), greater than Traws Pharma, Inc. (4.83M), greater than Elevation Oncology, Inc. (-7613691.00), greater than PHAXIAM Therapeutics S.A. (3.80M), greater than Pieris Pharmaceuticals, Inc. (-52477736.00), less than Dominari Holdings Inc. (64.62M), greater than Kineta, Inc. (7.37M), greater than Nymox Pharmaceutical Corporation (4.84M), greater than COSCIENS Biopharma Inc. (-645869.00), less than LakeShore Biopharma Co., Ltd (631.07M),

Build a custom stock screener for MEI Pharma, Inc. (MEIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MEI Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MEI Pharma, Inc. (MEIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MEI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is MEI Pharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for MEI Pharma, Inc. (MEIP)?

What is the 3-year average Enterprise Value for MEI Pharma, Inc. (MEIP)?

What is the 5-year average Enterprise Value for MEI Pharma, Inc. (MEIP)?

How does the current Enterprise Value for MEI Pharma, Inc. (MEIP) compare to its historical average?